FI20010115A0 - Menetelmä nanopartikkelien valmistamiseksi - Google Patents

Menetelmä nanopartikkelien valmistamiseksi

Info

Publication number
FI20010115A0
FI20010115A0 FI20010115A FI20010115A FI20010115A0 FI 20010115 A0 FI20010115 A0 FI 20010115A0 FI 20010115 A FI20010115 A FI 20010115A FI 20010115 A FI20010115 A FI 20010115A FI 20010115 A0 FI20010115 A0 FI 20010115A0
Authority
FI
Finland
Prior art keywords
particles
droplets
carrier gas
liquid feed
feed stock
Prior art date
Application number
FI20010115A
Other languages
English (en)
Swedish (sv)
Inventor
Wiwik Watanabe
Esko Kauppinen
Petri Ahonen
David Brown
Esa Muttonen
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Priority to FI20010115A priority Critical patent/FI20010115A0/fi
Publication of FI20010115A0 publication Critical patent/FI20010115A0/fi
Priority to EP02710900A priority patent/EP1351666B1/en
Priority to AT02710900T priority patent/ATE387185T1/de
Priority to JP2002557374A priority patent/JP4728558B2/ja
Priority to US10/466,365 priority patent/US20040091542A1/en
Priority to DE60225242T priority patent/DE60225242T2/de
Priority to PCT/FI2002/000042 priority patent/WO2002056866A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0004—Preparation of sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20010115A 2001-01-18 2001-01-18 Menetelmä nanopartikkelien valmistamiseksi FI20010115A0 (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20010115A FI20010115A0 (fi) 2001-01-18 2001-01-18 Menetelmä nanopartikkelien valmistamiseksi
EP02710900A EP1351666B1 (en) 2001-01-18 2002-01-18 A method for the preparation of nanoparticles
AT02710900T ATE387185T1 (de) 2001-01-18 2002-01-18 Verfahren zur herstellung von nanopartikeln
JP2002557374A JP4728558B2 (ja) 2001-01-18 2002-01-18 ナノ粒子の製造方法
US10/466,365 US20040091542A1 (en) 2001-01-18 2002-01-18 Method for the preparation of nanoparticles
DE60225242T DE60225242T2 (de) 2001-01-18 2002-01-18 Verfahren zur herstellung von nanopartikeln
PCT/FI2002/000042 WO2002056866A1 (en) 2001-01-18 2002-01-18 A method for the preparation of nanoparticles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20010115A FI20010115A0 (fi) 2001-01-18 2001-01-18 Menetelmä nanopartikkelien valmistamiseksi

Publications (1)

Publication Number Publication Date
FI20010115A0 true FI20010115A0 (fi) 2001-01-18

Family

ID=8560060

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20010115A FI20010115A0 (fi) 2001-01-18 2001-01-18 Menetelmä nanopartikkelien valmistamiseksi

Country Status (7)

Country Link
US (1) US20040091542A1 (fi)
EP (1) EP1351666B1 (fi)
JP (1) JP4728558B2 (fi)
AT (1) ATE387185T1 (fi)
DE (1) DE60225242T2 (fi)
FI (1) FI20010115A0 (fi)
WO (1) WO2002056866A1 (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US6900317B2 (en) 2002-02-19 2005-05-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
EP1625334B9 (en) 2003-05-21 2012-07-25 Alexza Pharmaceuticals, Inc. Percussively ignited self-contained heating unit
WO2005082589A1 (en) * 2004-02-24 2005-09-09 Luna Innovations Incorporated Process and systems for the efficient production of polymeric microspheres
DK2275098T3 (da) 2004-05-04 2012-08-20 Hormos Medical Ltd Hidtil ukendte orale formulationer af ospemifen
US8758821B2 (en) 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
JP6091041B2 (ja) * 2004-12-31 2017-03-08 イシューティカ ピーティーワイ リミテッド ナノ粒子組成物及びその合成方法
JP4979203B2 (ja) * 2005-05-31 2012-07-18 栗田工業株式会社 吸着構造体およびその製造方法
BRPI0613631A8 (pt) 2005-07-18 2017-12-26 Univ Massachusetts Lowell nanoemulsão e método,
US8318181B2 (en) * 2005-12-01 2012-11-27 University Of Massachusetts Lowell Botulinum nanoemulsions
US9486408B2 (en) * 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
CN1785153B (zh) * 2005-12-06 2010-04-21 青岛大学 纳米级材料制备装置及纳米抗氧化活性多肽药物的制备方法
US20070264350A1 (en) 2006-05-15 2007-11-15 Ebara Corporation Water-insoluble medicine
JP2007301534A (ja) * 2006-05-15 2007-11-22 Ebara Corp 微細化装置
DE102006026578B4 (de) * 2006-06-08 2009-01-08 Lts Lohmann Therapie-Systeme Ag Wirkstoffpartikelhaltiges Transdermales Therapeutisches System mit erhöhtem Wirkstofffluss und Verfahren zu seiner Herstellung sowie Verwendung
IN2014MN00380A (fi) 2006-06-30 2015-06-19 Iceutica Pty Ltd
CN101848702B (zh) 2006-12-01 2013-07-17 安特里奥公司 两亲实体纳米粒子
KR101518077B1 (ko) 2006-12-01 2015-05-28 안테리오스, 인코퍼레이티드 펩티드 나노입자 및 이의 용도
CA2672261C (en) * 2006-12-11 2014-09-23 Drugrecure Aps Methods for treating cystic fibrosis or pneumonia with bacterial infection via pulmonary administration of fosfomycin
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
ES2660906T3 (es) 2007-05-31 2018-03-26 Anterios, Inc. Nanopartículas de ácido nucleico y usos de las mismas
US20110182994A1 (en) * 2008-07-25 2011-07-28 S.K. Pharmaceuticals, Inc. Methods and systems for production of nanoparticles
DK2421513T3 (en) 2009-04-24 2018-03-26 Iceutica Pty Ltd UNKNOWN FORMULATION WITH INDOMETHACIN
DE102014011635A1 (de) 2013-09-04 2015-03-05 Chemiewerk Bad Köstritz GmbH Verfahren zur Herstellung von nanostrukturierbaren Mikropartikeln aus fluiden Medien mittels Sprühtrocknung
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
JP2019535829A (ja) 2016-11-21 2019-12-12 エイリオン セラピューティクス， インコーポレイテッド 大型薬剤の経皮送達
CN110232214B (zh) * 2019-05-09 2020-07-28 北京大学 一种通过数值模拟的食品预冷性能评估和优化方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3306250A1 (de) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen Sphaerische einkristalle fuer pharmazeutische zwecke
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
GB9105705D0 (en) * 1991-03-18 1991-05-01 Sandoz Ltd Improvements in or relating to organic compounds
AU660852B2 (en) * 1992-11-25 1995-07-06 Elan Pharma International Limited Method of grinding pharmaceutical substances
US5819726A (en) * 1993-01-29 1998-10-13 Aradigm Corporation Method for the delivery of aerosolized drugs to the lung for the treatment of respiratory disease
US5833892A (en) * 1996-07-12 1998-11-10 Kemira Pigments, Inc. Formation of TiO2 pigment by spray calcination
US6051257A (en) * 1997-02-24 2000-04-18 Superior Micropowders, Llc Powder batch of pharmaceutically-active particles and methods for making same
US6338809B1 (en) * 1997-02-24 2002-01-15 Superior Micropowders Llc Aerosol method and apparatus, particulate products, and electronic devices made therefrom

Also Published As

Publication number Publication date
DE60225242D1 (de) 2008-04-10
US20040091542A1 (en) 2004-05-13
EP1351666B1 (en) 2008-02-27
JP4728558B2 (ja) 2011-07-20
WO2002056866A1 (en) 2002-07-25
JP2004520157A (ja) 2004-07-08
DE60225242T2 (de) 2009-03-19
EP1351666A1 (en) 2003-10-15
ATE387185T1 (de) 2008-03-15

Similar Documents

Publication Publication Date Title
FI20010115A0 (fi) Menetelmä nanopartikkelien valmistamiseksi
Anderson et al. Magnetic functionalized nanoparticles for biomedical, drug delivery and imaging applications
US10980832B2 (en) Gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
CN101479051B (zh) 生产多层粒子、纤维和喷雾的系统和方法以及施用它们的方法
Raliya et al. Perspective on nanoparticle technology for biomedical use
Baldelli et al. Analysis of the particle formation process of structured microparticles
US8852644B2 (en) Method and device for producing microparticles or nanoparticles
Low et al. Sonoproduction of nanobiomaterials–A critical review
CA2829095A1 (en) Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
WO2011106565A1 (en) Methods and devices for controlling particle size and particle size distribution
Dheyab et al. Distinct advantages of using sonochemical over laser ablation methods for a rapid-high quality gold nanoparticles production
FI20002217A (fi) Inhalaatiopartikkelit
Soulé et al. Design and cellular fate of bioinspired Au–Ag Nanoshells@ Hybrid silica nanoparticles
JP3740152B2 (ja) 微細ゲル粒子の製造方法および製造装置
Brinkmann-Trettenes et al. Single step bottom-up process to generate solid phospholipid nano-particles
Patel et al. Ordered mesoporous silica nanocarriers: An innovative paradigm and a promising therapeutic efficient carrier for delivery of drugs
Chakraborty et al. Nano-dimensional gold synthesis for biomedical applications: upscaling and challenges
Bayer et al. Influence of nanosecond pulsed laser irradiance on the viability of nanoparticle-loaded cells: implications for safety of contrast-enhanced photoacoustic imaging
Brown et al. Advancements in using TiO2 bionanoconjugates for precision degradation of intracellular biological structures
Wang et al. Superparamagnetic Artificial Cells PLGA-Fe3O4 Micro/Nanocapsules for Cancer Targeted Delivery
Zhang et al. Continuous ammonium silicofluoride ammonification for SiO2 nanoparticles preparation in a microchemical system
Shin Low et al. Sonoproduction of nanobiomaterials–A critical review
Khurshid et al. Metallic Nanoparticles for Imaging and Therapy
Ni et al. Enhanced Stability and Photothermal Effect in the rGO/Au-Nanoprisms Hybrids
Movahedi et al. An experimental and numerical study of microfluidic preparation of chitosan nanoparticle